Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PRANSHU BANSAL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1447548722
CMS profile
155861
Location
MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$75,209.95

246 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $29,687.56 22
JAZZ PHARMACEUTICALS INC. $11,631.09 11
Janssen Biotech, Inc. $8,375.10 26
AstraZeneca Pharmaceuticals LP $7,380.43 26
Gilead Sciences, Inc. $4,937.09 15
E.R. Squibb & Sons, L.L.C. $4,371.21 10
Exelixis Inc. $4,165.68 14
Genentech USA, Inc. $1,130.06 4
Daiichi Sankyo Inc. $790.02 6
Novartis Pharmaceuticals Corporation $426.36 9
PFIZER INC. $234.96 12
Merck Sharp & Dohme LLC $211.12 12
Incyte Corporation $198.70 8
BeOne Medicines USA, Inc. $113.92 5
Lilly USA, LLC $106.77 4
Celgene Corporation $102.26 6
INTUITIVE SURGICAL, INC. $99.40 1
TerSera Therapeutics LLC $96.27 3
ABBVIE INC. $90.37 4
ARRAY BIOPHARMA INC $88.34 5
GENZYME CORPORATION $76.11 3
Merit Medical Systems Inc $71.34 1
Ipsen Biopharmaceuticals, Inc $57.67 3
Coherus Oncology, Inc. $56.05 3
Takeda Pharmaceuticals U.S.A., Inc. $53.63 2
ADC THERAPEUTICS AMERICA, INC. $46.82 2
Pharmacosmos Therapeutics Inc. $46.23 2
SpringWorks Therapeutics, Inc. $44.96 2
Astellas Pharma US Inc $44.67 2
Eisai Inc. $43.30 2
GlaxoSmithKline, LLC. $39.11 2
Iovance Biotherapeutics, Inc. $37.48 1
Caris MPI, Inc. $36.67 2
Bayer Healthcare Pharmaceuticals Inc. $32.77 2
Geron Corporation $29.85 1
SOBI, INC $28.37 1
Genmab U.S., Inc. $24.84 1
Blueprint Medicines Corporation $24.30 1
SERVIER PHARMACEUTICALS LLC $22.27 1
BeiGene USA, Inc. $22.09 1
RECORDATI_RARE_DISEASES_INC. $20.49 1
Acrotech Biopharma Inc. $18.44 1
Legend Biotech USA Inc. $18.26 1
SUN PHARMACEUTICAL INDUSTRIES INC. $17.20 1
Adaptive Biotechnologies Corporation $16.68 1
Myriad Genetic Laboratories, Inc. $15.31 1
PUMA BIOTECHNOLOGY, INC. $14.86 1
Karyopharm Therapeutics Inc. $13.47 1

Page 3 of 5; records 101–150 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PRANSHU BANSAL

NPI 1447548722 · CMS profile ID 155861

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

MESA, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447548722?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PRANSHU BANSAL, NPI 1447548722, CMS profile ID 155861. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447548722?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PRANSHU BANSAL, NPI 1447548722, CMS profile ID 155861. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447548722?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PRANSHU BANSAL, NPI 1447548722, CMS profile ID 155861, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1447548722?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

246 matching records · $75,209.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 246 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 246.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $23.6709/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207289370 CMS
Coherus Oncology, Inc. $23.9309/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235235480 CMS
Janssen Biotech, Inc. $96.2409/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174483794 CMS
AstraZeneca Pharmaceuticals LP $32.0009/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206269958 CMS
AstraZeneca Pharmaceuticals LP $218.6809/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206533809 CMS
RECORDATI_RARE_DISEASES_INC. $20.4908/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181712416 CMS
PFIZER INC. $19.1408/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229890522 CMS
Incyte Corporation $26.6108/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226155850 CMS
Regeneron Healthcare Solutions, Inc. $5,272.0008/22/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212868534 CMS
PFIZER INC. $18.8308/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229882163 CMS
ABBVIE INC. $15.6408/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201469579 CMS
Daiichi Sankyo Inc. $29.5808/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197014011 CMS
Ipsen Biopharmaceuticals, Inc $17.4608/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208844391 CMS
AstraZeneca Pharmaceuticals LP $33.1108/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206319725 CMS
AstraZeneca Pharmaceuticals LP $21.6908/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206948475 CMS
Caris MPI, Inc. $22.0308/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234278272 CMS
PFIZER INC. $24.1608/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229688975 CMS
AstraZeneca Pharmaceuticals LP $32.9108/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206585026 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.6808/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223886999 CMS
JAZZ PHARMACEUTICALS INC. $17.9107/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234340267 CMS
Novartis Pharmaceuticals Corporation $21.0207/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200027847 CMS
PUMA BIOTECHNOLOGY, INC. $14.8607/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251749992 CMS
TerSera Therapeutics LLC $32.7307/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244060980 CMS
AstraZeneca Pharmaceuticals LP $3,690.0007/28/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1206312970 CMS
Lilly USA, LLC $26.8307/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186760949 CMS
Merck Sharp & Dohme LLC $17.7907/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238321212 CMS
AstraZeneca Pharmaceuticals LP $281.3707/19/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1206563527 CMS
AstraZeneca Pharmaceuticals LP $37.5007/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206958234 CMS
AstraZeneca Pharmaceuticals LP $584.5007/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1207309410 CMS
E.R. Squibb & Sons, L.L.C. $20.3007/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184561677 CMS
Janssen Biotech, Inc. $155.4407/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174477383 CMS
Janssen Biotech, Inc. $2,860.0007/17/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1174486265 CMS
Janssen Biotech, Inc. $33.0007/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174486926 CMS
Lilly USA, LLC $25.0707/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186807301 CMS
ADC THERAPEUTICS AMERICA, INC. $25.6707/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246124808 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.7807/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225457323 CMS
Acrotech Biopharma Inc. $18.4407/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237535146 CMS
Genentech USA, Inc. $21.0907/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211568521 CMS
Janssen Biotech, Inc. $32.3607/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174484905 CMS
Iovance Biotherapeutics, Inc. $37.4807/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251400426 CMS
Regeneron Healthcare Solutions, Inc. $291.6007/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212868532 CMS
Genmab U.S., Inc. $24.8406/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235924995 CMS
Janssen Biotech, Inc. $150.0006/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174480418 CMS
PFIZER INC. $18.1206/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229316957 CMS
Janssen Biotech, Inc. $77.9906/23/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1174483655 CMS
PFIZER INC. $29.9106/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229329949 CMS
Celgene Corporation $18.0606/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184561667 CMS
AstraZeneca Pharmaceuticals LP $24.3206/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206713117 CMS
Janssen Biotech, Inc. $19.8206/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174485697 CMS
Regeneron Healthcare Solutions, Inc. $30.1606/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212868530 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $30,727.51 38
PY2020 $8,255.32 25
PY2021 $23,760.38 80
PY2022 $6,398.92 118
PY2023 $21,870.16 197
PY2024 $23,308.30 206
PY2025 $75,209.95 246

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $91,078.77 11
PY2023 Principal investigator $6,316.23 3
PY2022 Principal investigator $11,245.00 17
PY2021 Principal investigator $69,483.97 6
PY2020 Principal investigator $121,806.48 41
PY2019 Principal investigator $11,178.95 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,027.90 12/18/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202531128
Principal investigator 1 PFIZER INC. $23,590.88 12/15/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
AN INTERVENTIONAL PHASE 3 DOUBLEBLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228714267
Principal investigator 1 PFIZER INC. $356.50 12/15/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
AN INTERVENTIONAL PHASE 3 DOUBLEBLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228714871
Principal investigator 1 PFIZER INC. $461.25 12/15/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
AN INTERVENTIONAL PHASE 3 DOUBLEBLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228714873
Principal investigator 1 PFIZER INC. $19,908.70 12/15/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
AN INTERVENTIONAL PHASE 3 DOUBLEBLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228714875
Principal investigator 1 PFIZER INC. $2,987.04 12/15/2025 Non-covered Recipient Entity
Ironwood Cancer Research Centers
AN INTERVENTIONAL PHASE 3 DOUBLEBLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228714935
Principal investigator 1 ABBVIE INC. $5,651.24 12/04/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202526644
Principal investigator 1 ABBVIE INC. $1,534.40 11/14/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202524389
Principal investigator 1 ABBVIE INC. $4,238.43 11/05/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202523135
Principal investigator 1 ABBVIE INC. $4,238.43 10/09/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202516455
Principal investigator 1 ABBVIE INC. $23,084.00 09/04/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202510000